Journal of University Medical & Dental College,
Journal Year:
2022,
Volume and Issue:
13(3)
Published: Aug. 15, 2022
Vaccine
hesitancy
specifically
refers
to
refusal
receive
a
vaccine
shot
despite
its
availability.In
the
post
pandemic
era,
has
emerged
as
formidable
cause
for
global
concern.World
Health
Organization
(WHO)
[1]
now
grades
one
of
ten
significant
threats
health
care
systems,
which
adversely
impacted
health,
economy
and
social
life
around
globe
[4]
.This
is
no
more
problem
in
low-income
countries,
rather
equally
prevalent
high-income
however,
different
context
[3]
.The
anti-vaccination
moments
are
gaining
momentum
during
after
COVID
-19
first
waves.Vaccine
compromising
progress
made
against
COVID-19
resultant
low
vaccination
uptake
indicates
profound
weakness
country.Furthermore,
recent
body
evidence
suggested
that
even
healthcare
workers
were
also
sceptic
hesitant
jab
[5]
.viii
Tropical Medicine and Infectious Disease,
Journal Year:
2023,
Volume and Issue:
8(3), P. 159 - 159
Published: March 5, 2023
As
the
COVID-19
pandemic
continues
and
transitions
to
an
endemic
stage,
booster
vaccines
will
play
important
role
in
personal
public
health.
However,
convincing
people
take
boosters
be
a
key
obstacle.
This
study
systematically
analyzed
research
that
examined
predictors
of
vaccine
hesitancy.
A
search
PubMed,
Medline,
CINAHL,
Web
Science,
Scopus
uncovered
42
eligible
studies.
Globally,
average
vaccination
hesitancy
rate
was
30.72%.
Thirteen
factors
influencing
emerged
from
literature:
demographics
(gender,
age,
education,
income,
occupation,
employment
status,
ethnicity,
marital
status),
geographical
influences
(country,
region,
residency),
adverse
events,
perceived
benefit/efficacy,
susceptibility,
severity,
prior
history
infection,
recommendations,
health
knowledge
information,
skepticism/distrust/conspiracy
theories,
type.
Vaccine
communication
campaigns
interventions
for
COVID
should
focus
on
confidence,
complacency,
convenience.
Vaccines,
Journal Year:
2023,
Volume and Issue:
11(3), P. 623 - 623
Published: March 9, 2023
While
considerable
evidence
supports
the
safety
and
efficacy
of
COVID-19
vaccines,
a
sizable
population
expresses
vaccine
hesitancy.
As
per
World
Health
Organization,
hesitancy
is
one
top
10
hazards
to
global
health.
Vaccine
varies
across
countries,
with
India
reporting
least
was
higher
toward
booster
doses
than
previous
shots.
Therefore,
identifying
factors
determining
hesitance
(VBH)
sine
qua
non
successful
vaccination
campaign.This
systematic
review
followed
Preferred
Reporting
Items
for
Systematic
Reviews
Meta-analysis
(PRISMA)
2020
standards.
A
total
982
articles
were
pooled
from
Scopus,
PubMed
Embase,
while
42
that
addressed
VBH
finally
included
further
analysis.We
identified
responsible
divided
them
into
three
major
groups:
sociodemographic,
financial,
psychological.
Hence,
17
stated
age
be
factor
hesitancy,
most
reports
suggesting
negative
correlation
between
fear
poor
outcomes.
Nine
studies
found
females
expressing
greater
males.
Trust
deficit
in
science
(n
=
14),
concerns
about
12),
lower
levels
regarding
infection
11),
worry
side
effects
8)
also
reasons
Blacks,
Democrats,
pregnant
women
showed
high
Few
have
income,
obesity,
social
media,
living
vulnerable
members
as
influencing
study
44.1%
towards
could
attributed
dominantly
low
rural
origin,
previously
unvaccinated
status,
or
individuals.
However,
two
other
Indian
reported
lack
availability
slots,
trust
government,
doses.Many
confirmed
multifactorial
nature
VBH,
which
necessitates
multifaceted,
individually
tailored
interventions
address
all
potentially
modifiable
factors.
This
chiefly
recommends
strategizing
campaign
by
evaluating
appropriate
communication
(at
both
individual
community
levels)
benefits
risk
losing
immunity
without
them.
Vaccine X,
Journal Year:
2024,
Volume and Issue:
18, P. 100480 - 100480
Published: March 23, 2024
The
global
deployment
of
COVID-19
vaccine
booster
dose
(VBD)
has
been
recognized
as
a
promising
therapeutic
alliance
to
provide
repeated
immunity
against
the
arrival
new
variants.
Despite
scientific
evidence
supports
effectiveness
periodic
doses,
reluctance
continues
thrive.
This
narrative
review
aimed
examine
doses
acceptance
and
summarize
an
up-to-date
assessment
potential
antecedents
associated
with
VBD
acceptance.
A
comprehensive
search
was
performed
in
several
reputable
databases
such
Medline
(via
PubMed),
Scopus,
Google
scholar,
Web
Science
from
June
10th,
2023,
August
1st,
2023.
All
relevant
descriptive
observational
studies
on
hesitancy
were
included
this
review.
total
fifty-eight
(58)
included,
Asia
representing
highest
count
thirty-one
(53
%)
studies,
Europe
eleven
(19
%),
United
States
nine
(16
other
regions
(Africa
multi-ethnic)
seven
(12
%).
Worldwide,
pooled
rate
77.09
%
(95
CI:
76.28–78.18),
willingness
(n)
=
164189,
sample
(N)
212,990.
lowest
reported
American
regions,
respectively,
85.38
85.02–85.73,
32,047,
(N
37,533)
vs.
66.92
66.56–67.4),
29335,
43,832.
However,
multi-ethnic
areas
moderately
high
79.13
78.77–79.23,
93,994,
11,8779)
72.16
71.13–72.93,
9276,
12,853),
respectively.
most
common
key
across
countries
"equal
safety",
"efficacy",
"effectiveness",
post-vaccination
"side
effects",
"community
protection"
"family
protection",
"risk-benefit
ratio",
necessity",
"trust,
"variants
control".
Disparities
uptake
observed
globally,
rates
found
Europe,
regions.
Multiple
including
safety,
efficacy,
side
effects
hesitancy.
PLoS ONE,
Journal Year:
2025,
Volume and Issue:
20(1), P. e0312094 - e0312094
Published: Jan. 24, 2025
Background
Diabetes
mellitus
(DM)
is
a
global
health
problem.
Adherence
to
intensive
insulin
therapy
necessary
achieve
better
glycemic
control
in
types
1
and
2
DM.
This
study
aimed
evaluate
the
extent
of
adherence
therapy,
its
predictors
identify
barriers
adherence.
Method
was
cross-sectional
survey
among
adult
(≥18
years)
diabetic
patients
who
are
currently
using
insulin,
either
alone
or
combination
with
an
oral
antidiabetic
regimen,
seeking
primary
care
at
Kwame
Nkrumah
University
Science
Technology
Hospital
Ghana.
A
total
one
hundred
eight-six
were
conveniently
sampled,
interviewed.
Insulin
determined
Medication
Reporting
Scale-5.
Descriptive
statistics,
chi-square
test
independence,
multiple
logistic
regression
analysis
performed
STATA
version
14
(StataCorp,
TX
USA).
Results
The
majority
interviewed
over
60
years
(40.32%);
female
(61.83%);
married
(68.82%);
had
completed
secondary
education
(48.39%).
67.20%
adherent
therapy.
level
associated
age
(p
=
0.020),
marital
status
0.001),
employment
0.012),
type
DM
(p<0.001),
regular
follow-up
0.007)
comorbidities
0.002)
only
predicted
by
(aOR
14.82
C.I
1.34–163.50,
p-value
0.028).
Conclusion
our
population
suboptimal,
which
concern
considering
increased
risk
complications.
assessment
counselling
healthcare
professionals
address
poor
must
be
continually
undertaken
optimal
control.
Impact
findings
on
practice
statements
Continuous
offered
all
diabetes
as
part
their
ambulatory
help
improve
outcomes.
Using
Scale-5
determine
patient
levels
easy-to-use
inexpensive
method;
however,
it
should
used
caution
due
potential
for
misclassification.
Efforts
made
provide
appropriate
strategies
deal
clinics
individualized
comprehensive
reduce
Vaccines,
Journal Year:
2023,
Volume and Issue:
11(7), P. 1238 - 1238
Published: July 14, 2023
Severe
acute
respiratory
syndrome
coronavirus-2
(SARS-CoV-2)
has
affected
billions
of
lives
and
is
expected
to
impose
a
significant
burden
on
the
economy
worldwide.
Vaccination
only
way
prevent
infection.
However,
convincing
people
get
themselves
vaccinated
challenging
in
developing
countries
such
as
Pakistan.
Therefore,
cross-sectional
questionnaire-based
study
was
conducted
(n
=
982
participants)
all
over
Pakistan
evaluate
perception,
knowledge,
attitude,
acceptance
general
public
towards
SARS-CoV-2
vaccine,
general,
booster
dose
SARS-CoV-2,
particular.
The
highest
number
participants
were
from
province
Punjab
(84.5%),
followed
by
Islamabad
(3.8%),
Sindh
(3.7%),
Khyber
Pakhtunkhwa
(2.7%),
Baluchistan
(2.6%),
Gilgit
Baltistan
(1.4%),
Azad
Jammu
Kashmir
(1.4%).
A
total
915
against
COVID-19,
out
which
62.2%
received
one
dose,
double
doses
(25.5%)
single
vaccine
shots
(12.3%).
(85.8%),
(3.9%),
(2.8%);
(2.6%);
(2.3%);
Gilgit-Baltistan
(1.3%);
Azad,
Jammu,
(1.2%).
Among
individuals,
71.4%
unemployed,
27.4%
employed
(653),
1.2%
retired
service.
no
association
observed
among
genders
educational
levels
regard
vaccine.
outcomes
revealed
that
increased
vaccines
associated
with
intent
personal
family
protection.
Moreover,
individuals
low
socioeconomic
status
pregnant
females
showed
least
inoculation.
also
decline
trend
accepting
children.
Heliyon,
Journal Year:
2023,
Volume and Issue:
9(11), P. e22215 - e22215
Published: Nov. 1, 2023
Vaccine
booster
dose
(VBD)
provides
a
potential
therapeutic
alliance
in
preventing
breakthrough
infection
and
new
variant's
arrival
while
preserving
long-lasting
host
immunity.
This
study
aimed
to
analyze
COVID-19
VBD
willingness
identified
the
key
determinants
of
acceptance
among
general
people
Bangladesh.
survey-based
applied
quantitative
research
paradigm.
A
validated,
anonymous,
multi-item
questionnaire
was
adopted
through
theoretical
review
pertinent
literature
on
topic.
Data
were
collected
between
August
2022─October
2022,
sampling
done
randomly.
total
704
individuals
invited
via
face-to-face
interview
approach;
however,
13.8
%
them
declined
give
consent,
which
resulted
participation
607
respondents.
The
main
outcome
measure
willingness.
Binary
logistic
regression
analysis
conducted
rationalize
study's
objectives.
pooled
vaccine
rate
70.0
(95
confidence
Interval
[CI]:
67─73)
Bangladeshi
people.
An
binary
revealed
that,
out
14
factors,
"efficacy",
"repeated
immunity",
"communication",
"trust"
showed
highly
significant
positive
association
(adjusted
odds
ratio
[aOR
]
=
2.151
95
CI:
1.391─
3.508,
aOR
2.033
1.299─
3.181,
2.552
1.557─4.183
respectively,
p<0.01),
"equal
safety",
"risk-benefit
ratio"
"community
protection"
had
(aOR
1.739
1.070─2.825,
1.712
1.116─2.627,
1.628
1.395─0.998,
p<0.05)
with
acceptance.
However,
post-vaccination
"side
effects"
negative
0.393
0.237─0.674,
p<0.01)
associations
accepting
found
1.26,
it
insignificant
(p>0.05)
Chi-squared
test.
expressed
moderately
high
level
response
attitude
towards
is
an
this
study,
regardless
circumstances,
as
far
safety,
efficacy,
perceived
health
benefits,
communication,
trust,
community
resistance
are
concerned.
Post-vaccination
side
effects
fear
primary
reason
for
skepticism
well
barrier
administering
shots.
will
be
boosted
when
mass
effectively
communicated
vaccine's
data
become
more
available
publicly.
Vaccines,
Journal Year:
2022,
Volume and Issue:
10(10), P. 1736 - 1736
Published: Oct. 17, 2022
Background:
The
waning
vaccine
immunity
and
emergence
of
new
variants
SARS-CoV-2
led
health
authorities
across
the
globe
to
administer
booster
doses
(BDs)
COVID-19
vaccine.
Hence,
current
study
aimed
assess
hesitancy
(VBH)
amongst
Pakistani
healthcare
professionals
(HCPs).
Methods:
A
nationwide
survey-based
was
carried
out
from
April
2022
May
2022.
online
self-administered
questionnaire
utilized
collect
data
regarding
demographics
(age,
gender,
marital
status,
profession,
residential
area,
province),
infection
history
(infection
history,
onset,
clinical
severity
disease),
previous
vaccination
(type
number
doses),
attitudes
towards
BDs
(acceptance,
rejection,
hesitancy),
psychological
drivers
VBH
(perceived
effectiveness,
safety,
risk/benefit
ratio,
type
preference).
We
assessed
association
between
dependent
variable
participants,
independent
variables
(demographics,
vaccination,
VBH),
by
using
Chi-square
test/Fisher
exact
test.
Results:
Among
1164
51.4%
were
male,
80.4%
medical
professionals.
half
participants
(52.1%)
agreed
take
BD
or
had
already
taken
it,
while
rest
them
refused
(34.7%)
hesitated
(24.2%)
it.
These
significantly
associated
(p
<
0.001)
with
divers
about
BD.
Conclusion:
This
revealed
that
HCPs
hesitant
concerns
efficacy,
risk/benefits
ratio
vaccine’s
To
eliminate
hesitancy,
in
HCPs,
certain
educational
strategies
should
be
implemented
address
HCPs.
Vaccines,
Journal Year:
2022,
Volume and Issue:
11(1), P. 95 - 95
Published: Dec. 31, 2022
Vaccination
hesitance
for
the
COVID-19
booster
dosage
among
hemodialysis
patients
is
an
important
barrier
in
reducing
morbidity
and
mortality
linked
to
infection.
Hence,
this
study
aimed
explore
predictors
of
third
(booster)
dose
vaccine
intention
CKD
on
from
Kingdom
Saudi
Arabia
(KSA).This
was
a
multi-center
cross-sectional
conducted
at
four
dialysis
centers
KSA
13
February
2022
21
June
2022.
The
data
collected
by
nephrologist
charge
unit
using
structured
questionnaire,
which
consisted
parts;
socio-demographic
clinical
variables,
questions
about
infection
subjective
assessment
health
state,
vaccination
confidence
vaccines
preferences,
belief
model.
population
179
patients.Participants
had
conflicting
beliefs
their
vulnerability
severity
Study
participants
expressed
positive
advantages
dose,
reported
less
perceived
obstacles
receiving
vaccine.
influence
cues
action
high.
A
total
140
(78.2%)
receive
dose.
Patients
who
poor
self-rating
status
substantially
higher
definite
take
according
chi-square
test
(11.16,
df
=
3,
p
0.01).
There
significant
association
between
constructs
HBM
model
intention.
Marital
(OR
1.67,
CI
1.07-2.58)
found
be
strongest
Confidence
locally
manufactured
0.33,
0.17-0.60),
education
0.62,
0.41-0.93),
rating
0.43
0.25-0.74)
were
correlates
having
no
vaccination.HBM
significantly
associated
with
intention,
can
considered
while
planning
policies
promote
patients.
results
could
utilized
drafting
improve
uptake
population.
BMJ Open,
Journal Year:
2023,
Volume and Issue:
13(1), P. e066362 - e066362
Published: Jan. 1, 2023
Objective
To
gather
preliminary
insights
through
formative
research
on
social
media
usage,
and
experiences,
attitudes
perceptions
around
COVID-19
vaccination
in
three
high-risk,
underserved
districts
Karachi,
Pakistan.
Design
Cross-sectional
mixed-method
design.
Participants
392
adults
(361
surveys
30
in-depth
interviews
(IDI))
from
South,
East
Korangi
Main
outcome
measures
Social
usage
knowledge,
perception
behaviour
towards
infection
vaccination.
Results
Using
was
associated
with
an
increased
probability
of
getting
vaccinated
by
1.61
units.
Most
the
respondents
(65%)
reported
using
media,
mainly
to
watch
videos
and/or
keep
touch
family/friends.
84.76%
knew
while
88.37%
about
vaccination,
71.19%
vaccine
receipt;
reasons
vaccinate
included
belief
that
vaccines
protect
virus,
being
mandatory
for
work.
However,
only
56.7%
believed
they
were
at
risk
disease.
Of
54
unvaccinated
individuals,
27.78%
did
not
as
believe
COVID-19.
Despite
this,
78.38%
scored
high
confidence.
In
IDIs,
most
vaccines:
‘This
will
create
immunity
your
body.
Therefore,
I
think
we
should
get
vaccinated’,
over
half
how
spreads.
considered
a
serious
public
health
problem
thought
it
important
people
vaccinated.
there
low-risk
self
little
felt
contracting
Conclusion
With
our
conflicting
results
regarding
confidence,
is,
coverage
but
low
self,
is
likely
more
result
mandates
coercion
than
true
Our
findings
imply
interactive
could
be
valuable
fostering
provaccine
sentiment.
Vaccine X,
Journal Year:
2023,
Volume and Issue:
14, P. 100306 - 100306
Published: April 20, 2023
COVID-19
booster
vaccination
has
shown
to
add
the
protection
against
infection
with
SARS-CoV2
and
subsequent
severe
disease.
This
longitudinal
cross-border
study
aimed
identify
factors
associated
vaccine
intentions
in
an
initially
vaccinated
adult
population
living
Meuse-Rhine
Euroregion
(EMR;
including
Netherlands,
Belgium,
Germany)
differences
between
countries.
Data
collection
took
place
autumn
of
2021
consisted
online
questionnaires
sent
a
random
sample
based
on
governmental
registries.
from
3,319
fully
partially
adults
were
used
examine
determinants
non-positive
intention
for
(i.e.,
uncertain
or
do
not
want),
using
multivariable
logistic
regression
analyses
weighted
by
age
group,
sex,
country.
Compared
German
residents,
Dutch
residents
(OR
=
2.4)
Belgian
1.4)
more
likely
be
want
receive
September-October
2021.
Factors
independently
female
sex
1.6),
absence
comorbidities
1.3),
time
since
last
less
than
3
months
ago
those
being
3.6),
negative
experience
communication
measures
2.2),
regarding
as
ineffective
1.1).
Results
indicate
that
differ
countries
cross
border
Euroregion.
Non-positive
is
prevalent
all
three
EMR,
but
different
extent,
this
study.
Cross-border
collaboration
sharing
information
knowledge
about
strategies
could
play
role
limiting
impact
COVID-19.